Browse All

Current Filters

CLEAR FILTER x

TITLE

Effectiveness of Lower Rituximab Doses in Neuromyelitis Optica Spectrum Disorder: A Population-based Cohort Study

Author:Iordanova, Radostina   Smith, Jessica   Gonzales, Edlin   Lee, Angus   Li, Bonnie   Langer-Gould, Annette   

Session Name:S50: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:S50.006  

Author Institution:Los Angeles Medical Center, Southern California Permanente Medical Group, Los Angeles, CA  Southern California Permanente Medical Group, Pasadena, CA  

Associations Between Clinical Severity, Serological Testing, and Electrophysiological Profiles in Patients with Myasthenia Gravis

Author:Bigdeli, Ladan   Arnold, William   Kelly, Kristina   Elsheikh, Bakri   Mizell, Jordan   Paul, Samuel   

Session Name:P2: Neuromuscular Disease: Neuromuscular Junction Disorders 2  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P2.007  

Author Institution:The Ohio State University Wexner Medical Center, Columbus, OH  NextGen Precision Health, University of Missouri, Columbia, MO  

RNAseq transcriptome profiling reveals activation of immune responses and disrupted circadian patterns in the cerebral white matter of aged mice

Author:Ishikawa, Hidehiro   Hamanaka, Gen   Mandeville, Emiri   Guo, Shuzhen   Li, Wenlu   Shindo, Akihiro   Lo, Eng   Arai, Ken   

Session Name:P4: Aging and Dementia: Emerging Topics  

Topic:Aging and Dementia  

Program Number:P4.003  

Author Institution:Massachusetts General Hospital and Harvard Medical School, Boston, MA  Mie University, Mie, Japan  

Predicting the Final Clinical Phenotype after the First Attack of Optic Neuritis

Author:Sarin, Shlok   Modak, Nikhil   Sun, Rongyi   Subei, Omar   Serra, Alessandro   Morgan, Michael   Abboud, Hesham   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.017  

Author Institution:Case Western Reserve University School of Medicine, Cleveland Heights, OH  University Hospitals Cleveland Medical Center, Cleveland, OH  Case Western Reserve University School of Medicine, Cleveland, OH  Duke University, Durham, NC  

FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)

Author:Darras, Basil   Baranello, Giovanni   Boespflug-Tanguy, Odile   Day, John   Deconinck, Nicholas   Klein, Andrea   Masson, Ricardo   Mazurkiewicz-Beldzinska, Maria   Mercuri, Eugenio   Rose, Kristy   Vlodavets, Dmitry   Xiong, Hui   Zanoteli, Edmar   El-Khairi, Muna   Gerber, Marianne   Gorni, Ksenija   Kletzl, Heidemarie   Palfreeman, Laura   Dodman, Angela   Servais, Laurent   

Session Name:P7: Child Neurology and Developmental Neurology: Spinomuscular Atrophy/Muscular Dystrophies  

Topic:Child Neurology and Developmental Neurology  

Program Number:P7.009  

Author Institution:Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA  Dubowitz Neuromuscular Centre, University College London, London, UK  Developmental Neurology, Istituto Neurologico C Besta, Milan, Italy, London, United Kingdom  IMotion Institut de Myologie AP-HP, Hôpital Armand Trousseau, Paris, France  Université Paris Cité, UMR 1141, NeuroDiderot, Paris, France, Paris, France  Stanford University, Palo Alto, CA, USA, Palo Alto, CA  Neuromuscular Center, UZ Gent, Ghent, Belgium  Centre de Référence des Maladies Neuromusculaires, Children’s University Hospital, ULB, Brussels, Belgium, Ghent, Belgium  Paediatric Neurology, Uni. Children’s Hospital Basel, Basel, Switzerland  Paediatric Neurology, Inselspital, University of Bern, Bern, Switzerland, Basel, Switzerland  Developmental Neurology, Istituto Neurologico C Besta, Milan, Italy, Milan, Italy  Developmental Neurology, Medical University of Gdansk, Gdansk, Poland, Gdansk, Poland  Pediatric Neurology Institute, Catholic University, Rome, Italy, Rome, Italy  Paediatric Gait Analysis Service of New South Wales, The Children’s Hospital at Westmead, Sydney, Australia, Sydney, Australia  Children Neuromuscular Center, Pirogov Medical University, Moscow, Russia, Moscow, Russian Federation  Department of Pediatrics, Peking University First Hospital, Beijing, China, Beijing, China, People's Republic of  Department of Neurology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, Sao Paulo, Brazil  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Pharma Development, Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  PDMA Neuro/Rare Disease, F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Pharmaceutical Research, Roche Innovation Center Basel, Basel, Switzerland, Basel, Switzerland  Pharma Development Neuro, F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  MDUK Oxford Neuromuscular Centre, Department of Paediatrics, University of Oxford, Oxford, UK  Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University of Liège, Liège, Belgium, Oxford, United Kingdom